PMID: 7017691Jan 1, 1980Paper

Outcome of repeated renal regrafting

Proceedings of the European Dialysis and Transplant Association
B FriskL E Gelin

Abstract

Fifteen patients underwent renal transplantation 4 and in one case 5 times. 7/15 grafts (47%) survived more than one year. The one year graft loss due to rejection was 40%. Seven patients are currently alive -- five with excellent graft function and optimal rehabilitation. Two patients are back and well on dialysis. Standard operation technique worked well in all cases. In our opinion repeated renal regrafting is a well worthwhile procedure.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Transplant International : Official Journal of the European Society for Organ Transplantation
Armin D GoralczykThomas Lorf
Transplant International : Official Journal of the European Society for Organ Transplantation
G TufvesonB Wikström
© 2021 Meta ULC. All rights reserved